Treatment of nonsurgical refractory back pain with high-frequency spinal cord stimulation at 10 kHz: 12-month results of a pragmatic, multicenter, randomized controlled trial

医学 随机对照试验 随机化 Oswestry残疾指数 背痛 生活质量(医疗保健) 观察研究 耐火材料(行星科学) 慢性疼痛 外科 人口 物理疗法 腰痛 内科学 护理部 病理 替代医学 物理 环境卫生 天体生物学
作者
Leonardo Kapural,Jessica Jameson,Curtis D. Johnson,Daniel Kloster,Aaron Calodney,Peter Kosek,Julie G. Pilitsis,Markus A. Bendel,Erika Petersen,Chengyuan Wu,Taissa Cherry,Shivanand P. Lad,Cong Yu,Dawood Sayed,Johnathan Goree,Mark Lyons,Andrew Sack,Diana Bruce,Frances Rubenstein,Rose Province‐Azalde,David Caraway,Naresh P. Patel
出处
期刊:Journal of neurosurgery [Journal of Neurosurgery Publishing Group]
卷期号:37 (2): 188-199 被引量:41
标识
DOI:10.3171/2021.12.spine211301
摘要

OBJECTIVE Spinal cord stimulation (SCS) at 10 kHz (10-kHz SCS) is a safe and effective therapy for treatment of chronic low-back pain. However, it is unclear from existing evidence whether these findings can be generalized to patients with chronic back pain that is refractory to conventional medical management (CMM) and who have no history of spine surgery and are not acceptable candidates for spine surgery. The authors have termed this condition "nonsurgical refractory back pain" (NSRBP) and conducted a multicenter, randomized controlled trial to compare CMM with and without 10-kHz SCS in this population. METHODS Patients with NSRBP, as defined above and with a spine surgeon consultation required for confirmation, were randomized 1:1 to patients undergoing CMM with and without 10-kHz SCS. CMM included nonsurgical treatment for back pain, according to physicians’ best practices and clinical guidelines. Primary and secondary endpoints included the responder rate (≥ 50% pain relief), disability (Oswestry Disability Index [ODI]), global impression of change, quality of life (EQ-5D-5L), and change in daily opioid use and were analyzed 3 and 6 months after randomization. The protocol allowed for an optional crossover at 6 months for both arms, with observational follow-up over 12 months. RESULTS In total, 159 patients were randomized; 76 received CMM, and 69 (83.1%) of the 83 patients who were assigned to the 10-kHz SCS group received a permanent implant. At the 3-month follow-up, 80.9% of patients who received stimulation and 1.3% of those who received CMM were found to be study responders (primary outcome, ≥ 50% pain relief; p < 0.001). There was also a significant difference between the treatment groups in all secondary outcomes at 6 months (p < 0.001). In the 10-kHz SCS arm, outcomes were sustained, including a mean 10-cm visual analog scale score of 2.1 ± 2.3 and 2.1 ± 2.2 and mean ODI score of 24.1 ± 16.1 and 24.0 ± 17.0 at 6 and 12 months, respectively (p = 0.9). In the CMM arm, 74.7% (56/75) of patients met the criteria for crossover and received an implant. The crossover arm obtained a 78.2% responder rate 6 months postimplantation. Five serious adverse events occurred (procedure-related, of 125 total permanent implants), all of which resolved without sequelae. CONCLUSIONS The study results, which included follow-up over 12 months, provide important insights into the durability of 10-kHz SCS therapy with respect to chronic refractory back pain, physical function, quality of life, and opioid use, informing the current clinical practice for pain management in patients with NSRBP.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇应助lelele采纳,获得10
刚刚
ljy发布了新的文献求助10
1秒前
1秒前
玛卡巴卡发布了新的文献求助10
1秒前
咻咻发布了新的文献求助20
2秒前
2秒前
范冰冰发布了新的文献求助10
2秒前
邢文瑞完成签到,获得积分10
2秒前
搜集达人应助俭朴的乐巧采纳,获得10
2秒前
3秒前
斯文败类应助零零采纳,获得10
3秒前
星辰大海应助辣目童子采纳,获得10
3秒前
仿生人发布了新的文献求助10
4秒前
5秒前
囿于昼夜完成签到,获得积分10
6秒前
6秒前
邢文瑞发布了新的文献求助10
6秒前
7秒前
Orange应助橙子采纳,获得10
7秒前
ED应助坚定的语芙采纳,获得10
8秒前
8秒前
lzx应助小猛人采纳,获得50
8秒前
霏166发布了新的文献求助10
9秒前
10秒前
10秒前
dxk发布了新的文献求助10
11秒前
ding应助Hexagram采纳,获得10
11秒前
欢呼寒珊完成签到,获得积分10
12秒前
卡卡西应助glanceofwind采纳,获得20
12秒前
ss完成签到,获得积分10
12秒前
FashionBoy应助Cool采纳,获得10
12秒前
刺1656发布了新的文献求助10
13秒前
炙热雅琴发布了新的文献求助10
14秒前
大大大长腿完成签到,获得积分10
16秒前
Pepsi完成签到,获得积分10
16秒前
xuliangzheng完成签到,获得积分20
17秒前
量子星尘发布了新的文献求助10
17秒前
华仔应助wgr采纳,获得10
17秒前
18秒前
萧凌翠完成签到,获得积分20
19秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976058
求助须知:如何正确求助?哪些是违规求助? 3520294
关于积分的说明 11202245
捐赠科研通 3256804
什么是DOI,文献DOI怎么找? 1798471
邀请新用户注册赠送积分活动 877610
科研通“疑难数据库(出版商)”最低求助积分说明 806496